This week, we will discuss the role of ApoE in determining the subtypes of C3 Glomerulopathy.
Optimizing “Sparse” Treatments for FSGS
SPARE a Thought for SPARSENTAN?
MMF in IgA: Inching into the MAINstream?
NefIgArdians of The Glomerular Galaxy
2021 KDIGO Updates for Glomerular Disease: The Visual Abstract
This update was too big for just one slide! Michael Turk produced two Visual Primers to help you understand the 2021 GN changes at-a-glance.